查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1190803

體外除顫器市場-增長、趨勢、COVID-19 的影響和預測 (2023-2028)

External Defibrillator Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在心髒病患者不斷增加以及政府和大公司對公眾使用除顫器 (PAD) 的關注增加的推動下，預測期內體外除顫器市場預計將以 7.62% 的複合年增長率增長。

COVID-19 大流行通過直接影響生產和需求而影響了全球經濟。 然而，COVID-19影響心血管系統並引起心肌梗塞、心律失常、血管內血栓形成和心源性猝死等心髒病。 住院患者報告了許多心律失常病例，而自大流行開始以來，心臟驟停 (SCA) 一直是臨床醫生關注的問題。 這種病例的增加增加了對體外除顫器的需求，因為它們是心血管疾病 (CVD) 的有效干預措施。

由於全球人口久坐不動的生活方式和日益老齡化的人口，心髒病的負擔正在增加。 2019 年 4 月發表在《心血管發展與疾病雜誌》上的文章“Cardiovascular Risks Associated with Gender, and Aging”表明，衰老和老年人特別容易患心血管疾病和心髒病。 此外，與老年密切相關的風險因素是虛弱、肥胖和糖尿病，據報導，這些因素會使患心血管疾病的風險增加一倍，而且心血管疾病的可能性會隨著年齡的增長而增加。

根據澳大利亞健康與福利研究所2021年9月更新的論文《心臟、中風和血管疾病-澳大利亞事實》，2019年心血管疾病死亡人數為42300人，為澳大利亞整體最高。它佔全澳的5%死亡人數。 這些高死亡率導致了對體外除顫器的需求，並且這種對體外除顫器的需求增加預計將推動研究市場的增長。

2020 年 7 月，ZOLL Medical Corporation（旭化成集團公司）在其專為緊急醫療服務 (EMS) 機構開發的 X 系列監護儀/除顫器中採用了新的遠程查看技術。現已開始銷售。 同樣在 2021 年 10 月，威爾士橄欖球聯盟 (WRU) 將與慈善機構 Calon Hearts 和邁瑞的經銷商合作，通過合作將邁瑞的 C 系列自動化外用輔料帶到威爾士的 300 多個俱樂部。我能夠從除顫器 (AED) 中受益). 體外除顫器領域的這些技術進步和主要市場參與者推出的新產品正在推動所研究市場的增長，體外除顫器市場在預測期內將繼續表現良好，有望呈現增長。

然而，缺乏對心臟驟停 (SAC) 的認識，加上嚴格的法規和頻繁的產品召回，可能會限制體外除顫器市場的增長。

體外除顫器市場趨勢

按產品類型劃分，自動體外除顫器 (AED) 預計將主導市場

按產品細分，自動體外除顫器 (AED) 預計將在預測期內促進體外除顫器市場的增長。 自動體外除顫器 (AED) 主要存在於公共訪問環境中，供非醫務人員使用。 這意味著，如果有人心臟驟停，附近的人可以在救護車到達之前進行心肺復蘇並使用 AED。 當 AED 用戶按照說明操作時，AED 將自動啟動。 這增加了對 AED 的需求，並推動了自動體外除顫器市場的增長。

隨著壓力大的工作環境、久坐不動的生活方式以及煙草、酒精和藥物濫用的增加，不同年齡組的心髒病患病率正在上升，這表明 AED 的需求不斷增加。

心房顫動 (A-fib) 是一種心律不規則且通常非常快的疾病，可導致心臟血栓，導致中風、心力衰竭和其他與心臟相關的並發症。導致它。 一篇題為《全球房顫流行病學》的論文報導稱，全球房顫患病率為375.74億例，比過去二十年增長了33%。 “日益嚴重的流行病和公共衛生挑戰”，發表於 International Journal of Stroke，2020 年 1 月。 該論文還報告稱，到 2050 年房顫的絕對負擔可能增加 60% 以上。 美國心髒病學會基金會在其 2021 年 3 月的出版物“ACC 的創新：了解家用 AED 的價值”中發現，公眾使用 AED 改變了心臟驟停的存活率，大約 70% 的心臟驟停發生在家中，並且有機會向心臟驟停風險人群的家庭提供家用 AED。

AED 主要用於通過自動功能校正患者的心率，並且由於任何旁觀者只需按照其說明即可在任何位置輕鬆使用它們，因此它們可用於公共和家庭自動化外部應用。它創建對除顫器可用性的需求，預計這將在預測期內直接推動監測市場的增長。

自動體外除顫器 (AED) 有助於糾正心率，而與心臟驟停相關的死亡人數不斷增加也增加了對 AED 的需求。 世界衛生組織 (WHO) 於 2021 年 6 月發表的題為“心血管疾病 (CVDs)”的論文報告稱，心血管疾病是全球第一大死因。 文章稱，2019年約有1790萬人死於心血管疾病（CVD），佔全球所有死亡人數的32%，其中85%死於心髒病和中風。據估計，有 因此，由於這些心髒病導致的死亡人數不斷增加，增加了對 AED 的需求，這相應地推動了所研究市場的增長，預計該市場在預測期內也會增長。

預計在預測期內北美將主導體外除顫器市場

北美體外除顫器 (ED) 市場受到心血管疾病高負擔和日益流行、新產品發布以及美國和該地區其他地區主要市場參與者崛起的推動。預計在預測期內增長。

根據美國心臟協會 (AHA) 心髒病和中風統計數據 - 2022 年更新數據，心血管疾病 (CVD) 是美國主要的根本死因，2019 年導致 874,613 人死亡。平均而言，每3 分 30 秒有人中風，每 40 秒有人死於心髒病。 國內人口中如此高的心髒病患病率已經收穫了對體外除顫器的需求，因為它們可以糾正心律並挽救生命。 對緊急醫療護理不斷增長的需求正在推動研究目標市場的增長。

該地區對體外除顫器的使用率很高，對心臟驟停 (SAC) 的意識也很強。繼續為體外除顫器 (ED) 市場的增長做出貢獻。 例如，在 2021 年 10 月心臟驟停宣傳月期間，PulsePoint 基金會將舉辦 PulsePoint AED 競賽，而 2021 年 11 月，PulsePoint 基金會將在俄亥俄州費爾菲爾德縣舉辦首屆 Pulse Point AED 競賽並宣布獲勝5,000 美元用於資助公共安全人員和社區購買 AED（自動體外除顫器）。

該地區的主要參與者正在合作、協作、兼併和收購方面採取新步驟，以徹底改變市場並推動所研究市場的增長。 2021 年 8 月，提供自動體外除顫器 (AED) 以及全球首個院外心臟驟停 (OHCA) 響應平台的 Alive Solutions, Inc. 宣布與 RapidSOS 合作，在關鍵時刻提供心臟護理。宣佈為垂死患者提供救生 AED，並向電信運營商提供前所未有的發病率數據，以更順暢、更有效地協調救生護理。 此外，在 2021 年 9 月，Stryker Corporation 和 Lacrosse USA 將合作成為美國 Lacrosse 和美國國家隊的官方 AED 供應商，通過此合作，Lacrosse USA 的成員將獲得 Stryker AED 設備的折扣。我能夠做到。

此類舉措、合作夥伴關係和產品發布擴大了該地區的市場規模，預計在預測期內將繼續擴大。

體外除顫器市場競爭分析

就競爭而言，體外除顫器市場相當分散。 對公司的競爭分析表明，大多數公司都將重點放在新產品發布、合作夥伴關係和企業收購上，以擴大業務。 目前主導市場的公司包括 Asahi Kasei Corporation (Zoll Medical Corporation)、Koninklijke Philips NV (Philips Healthcare)、Nihon Kohden Corporation (Defibtech LLC)、Schiller Americas Inc. (Schiller Ag)、深圳邁瑞生物醫療電子、Stryker、CU Medical System、Mediana、BPL Medical Technologies、Heartsine Technologies Ltd 和 ViVest Medical Technology。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 心髒病發病率增加
    • 技術先進的除顫器的可用性
    • 私營公司的投資增加
    • 公共接入除顫器 (PAD) 受到政府和主要參與者的關注
  • 市場製約因素
    • 缺乏對心臟驟停 (SAC) 的認識
    • 嚴格的法規和頻繁的產品召回
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按產品分類
    • 手動體外除顫器
    • 自動體外除顫器 (AED)
    • 可穿戴除顫器 (WCD)
  • 最終用戶
    • 醫院和診所
    • 家庭護理
    • 其他最終用戶
  • 按地區細分
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 英國
      • 法國
      • 德國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 印度
      • 中國
      • 日本
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Asahi Kasei Corporation（Zoll Medical Corporation）
    • Koninklijke Philips NV（Philips Healthcare）
    • Nihon Kohden Corporation（Defibtech LLC）
    • Schiller Americas Inc.（Schiller Ag）
    • Shenzhen Mindray Bio-Medical Electronics Co. Ltd
    • Stryker
    • CU Medical System
    • Mediana Co. Ltd
    • BPL Medical Technologies
    • Heartsine Technologies Ltd
    • ViVest Medical Technology Co. Ltd

第7章 市場機會與今後動向

簡介目錄
Product Code: 72516

The external defibrillator market is expected to register a CAGR of 7.62% during the forecast period due to the increasing number of cardiac patients and the rising focus by government and major players on Public Access Defibrillators (PADs).

The COVID-19 pandemic has affected the global economy by directly affecting production and demand. However, the COVID-19 affected the cardiovascular system and caused heart diseases like myocardial injury, arrhythmias, intravascular thrombosis, and sudden cardiac death. A number of cases of Arrhythmias have been reported among hospitalized patients, while Sudden cardiac arrest (SCA) has been an alarming concern for clinicians since the pandemic started. This increased burden of the cases raised the demand for external defibrillators as the external defibrillator is an effective intervention for cardiovascular diseases (CVDs).

Due to the existing sedentary lifestyle among the population and the growing geriatric population around the world, the burden of cardiac diseases is rising. According to the Journal of Cardiovascular Development and Disease article titled Cardiovascular Risks Associated with Gender, and Aging, published in April 2019, the aging and elderly population are particularly susceptible to cardiovascular or heart diseases suggest. It also reported that the risk factors strongly associated with advanced age are frailty, obesity, and diabetes, which have been shown to multiply the risks of getting cardiovascular disease and the chances of cardiovascular diseases increase with age.

In 2019, cardiovascular diseases accounted for 42,300 deaths, 5% of all deaths in Australia, according to the Australia Institute of Health and Welfare article titled Heart, stroke and vascular disease-Australian facts, which was updated in September 2021. These high number of occurrence of deaths generated a need for external defibrillators, and this increasing demand for external defibrillators is likely to drive the growth of the studied market.

In July 2020, ZOLL Medical Corporation (Asahi Kasei Group company) launched its new remote view technology on the X Series monitor/defibrillator specially developed for Emergency Medical Services (EMS) agencies. Again, in October 2021, the Welsh Rugby Union (WRU) partnered with Calon Hearts charity and Mindray distributor, and with this partnership, over 300 clubs across Wales benefited from Mindray's C Series automated external defibrillators (AEDs). These technological advancements in the external defibrillator field and the new product launches by the key market players are boosting the growth of the studied market, and the external defibrillator market is projected to witness lucrative growth during the forecast period as well.

However, the lack of awareness about the sudden cardiac arrest (SAC), coupled with stringent regulations and frequent product recalls, may restrain the growth of the external defibrillator market.

External Defibrillator Market Trends

Automated External Defibrillator (AED) is Expected to Dominate the Market in the Product Type Segment

The automated external defibrillator (AED) by product segment is expected to contribute to the growth of the external defibrillator market in the forecast period. Due to the fact that manual external defibrillators require more experience and training for effective handling, they are present in hospitals and a few ambulances, but automated external defibrillators (AED) are mostly found in public access settings and are meant to be used by non-medical personnel. That means if someone suffers sudden cardiac arrest, people nearby can provide CPR and use an AED before the ambulance arrives because when turned on, the AED will give the user step-by-step directions to deliver a shock if it is needed. The person using the AED just needs to follow the step-by-step instructions, and the AED will start functioning automatically. This increases the demand for the AED and increases the growth of the automated external defibrillator segment.

Due to the rising prevalence of cardiac diseases across different age groups due to stressful work conditions, a sedentary lifestyle accompanied by growing consumption of tobacco, alcohol, and substance abuse is increasing the demand for AEDs.

Atrial fibrillation (A-fib) is a condition of irregular and often very rapid heart rhythm, which can also lead to blood clots in the heart, causing the risk of stroke, heart failure, and other heart-related complications. The global prevalence of atrial fibrillation is 37,574 million cases, which increased by 33% during the last 20 years, reported in an article titled Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge, published in the International Journal of Stroke in January 2020. This article also reported that the absolute atrial fibrillation burden may increase by more than 60% in 2050. American College of Cardiology Foundation, in its Innovation at ACC | Understanding the Value of AEDs at Home article published in March 2021, mentioned that public access to the AEDs had altered the survival rate of a sudden cardiac arrest, but nearly 70% of the cardiac arrests occur at home, and this creates an opportunity for providing at-home AEDs in the homes for risk of cardiac arrest populations.

Due to AEDs majorly used in correcting patients' heartbeats through automated functions, and these are easy to use for any bystanders at any place by simply following the instructions, this creates demand for the availability of automated external defibrillators in public and at home, and this is expected to directly drive the growth of the studied market over the forecast period.

As the automated external defibrillator (AED) is helpful in cardiac rhythm corrections, the demand for AED is increasing due to the increasing number of deaths related to cardiac arrests. The World Health Organization (WHO)'s article titled Cardiovascular diseases (CVDs) published in June 2021, reported that cardiovascular diseases were the leading cause of death globally. According to the same article, in 2019, it was estimated that approximately 17.9 million people died from cardiovascular diseases (CVDs), which represented 32% of all global deaths, and among them, 85% accounted for heart attack and stroke. Therefore, these increasing numbers of cardiac deaths are increasing the demand for the AED, which is proportionally driving the growth of the studied market and is also expected to grow during the forecast period.

North America Expected to Dominate the External Defibrillators Market in the Forecast Period

The North American external defibrillators (EDs) market is expected to grow during the forecast period due to the high burden and increasing prevalence of cardiovascular diseases, new product launches, and the emerging number of key market players in United States and other countries in the region.

The American Heart Association (AHA), Heart Disease and Stroke Statistics - 2022 Update data shows that in United States, cardiovascular disease (CVD) is listed as the primary underlying cause of death, and this accounted for 874,613 deaths in 2019 and on average, every 3 minutes and 30 seconds, someone died out of a stroke, and every 40 seconds, someone died of myocardial infarction in United States. Such a high prevalence of cardiac diseases among the population in the country reaped the demand for external defibrillators as these can modify the rhythm of the heart and can be lifesaving. This increasing demand for EDs is driving the growth of the studied market.

The region has high access to the external defibrillators and has awareness about Sudden Cardiac Arrest (SAC), followed by initiatives taken by the government and private organizations for easy availability of the external defibrillators is contributing to the growth of the external defibrillators (EDs) market. For instance, In October 2021, Sudden Cardiac Arrest Awareness Month, the PulsePoint Foundation organized a PulsePoint AED Contest, and in November 2021, the PulsePoint Foundation announced that Fairfield County, Ohio, won the inaugural Pulse Point AED Contest and won a grant of USD 5,000 to purchase AEDs (Automated External Defibrillators) for public safety staff and the community.

The major players present in the region are taking new steps in terms of partnerships, collaborations, mergers, and acquisitions to bring revolution to the market, driving the growth of the studied market. In August 2021, Avive Solutions Inc., a global provider of Automated External Defibrillators (AED), coupled with a first of its kind out-of-hospital cardiac arrest (OHCA) response platform, announced a partnership with RapidSOS to provide lifesaving AEDs to cardiac arrest patients in crucial times and provide telecommunicators with unprecedented occurrence data to help them more seamlessly and effectively coordinate lifesaving care. Again, in September 2021, Stryker Corporation and United States Lacrosse partnered to serve as the Official AED provider for United States Lacrosse and United States National Teams, and with this partnership, United States Lacrosse members received Stryker AED devices at discounted prices.

Therefore, owing to all these initiatives, partnerships, and product launches, the growth of the overall market in the region has grown and is expected to continue the same trend over the forecast period.

External Defibrillator Market Competitive Analysis

The external defibrillator market is fairly fragmented in terms of competition. The competitive analysis of the companies reveals that most of the companies are concentrating on new product launches and partnerships, and acquisitions for the expansion of their business. Some of the companies currently dominating the market include Asahi Kasei Corporation (Zoll Medical Corporation), Koninklijke Philips NV (Philips Healthcare), Nihon Kohden Corporation (Defibtech LLC), Schiller Americas Inc. (Schiller Ag), Shenzhen Mindray Bio-Medical Electronics Co. Ltd, Stryker, CU Medical System, Mediana Co. Ltd, BPL Medical Technologies, Heartsine Technologies Ltd, and ViVest Medical Technology Co. Ltd.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in Incidence of Cardiac Diseases
    • 4.2.2 Availability of Technologically Advanced Defibrillators
    • 4.2.3 Increasing Investments by Private Players
    • 4.2.4 Rising Focus by Government and Major Players toward Public Access Defibrillator (PAD)
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness about Sudden Cardiac Arrest (SAC)
    • 4.3.2 Stringent Regulations and Frequent Product Recalls
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Manual External Defibrillator
    • 5.1.2 Automated External Defibrillator (AED)
    • 5.1.3 Wearable Cardioverter Defibrillator (WCD)
  • 5.2 By End User
    • 5.2.1 Hospitals and Clinics
    • 5.2.2 Home Care
    • 5.2.3 Other End Users
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 United Kingdom
      • 5.3.2.2 France
      • 5.3.2.3 Germany
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 India
      • 5.3.3.2 China
      • 5.3.3.3 Japan
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 COMPANY PROFILES
    • 6.1.1 Asahi Kasei Corporation (Zoll Medical Corporation)
    • 6.1.2 Koninklijke Philips NV (Philips Healthcare)
    • 6.1.3 Nihon Kohden Corporation (Defibtech LLC)
    • 6.1.4 Schiller Americas Inc. (Schiller Ag)
    • 6.1.5 Shenzhen Mindray Bio-Medical Electronics Co. Ltd
    • 6.1.6 Stryker
    • 6.1.7 CU Medical System
    • 6.1.8 Mediana Co. Ltd
    • 6.1.9 BPL Medical Technologies
    • 6.1.10 Heartsine Technologies Ltd
    • 6.1.11 ViVest Medical Technology Co. Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS